ecancermedicalscience

Submit article

https://doi.org/10.3332/ecancer.2022.1340

Abstract | Full Article |

Short Communication

Clinical research in oncology: in memory of Professor Gordon McVie

13 Jan 2022

Ian F Tannock

Gordon McVie campaigned throughout his career for merging scientific and clinical expertise and for investigating the underlying pharmacokinetics and pharmacodynamics in clinical trials. This need remains highly relevant today when most cancer clinical trials investigate agents that target a known molecular pathway, yet anticancer drug development has changed minimally from that used for chemotherapy when more was better and substantial toxicity inevitable. Here, I summarise some common problems that confound current drug development, including problems in interpreting results of phase 3 randomised trials, as well as trials investigating personalised medicine.

Article metrics: 677 views

424

253

2150-safety-of-immune-checkpoint-inhibitors-in-a-diverse-patient-population-a-single-institution-experience

Short Communication: Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience

Grace M Ferri*, John F Murphy*, Akash Oza*, Alexander J B Bulteel, Wafaa Abbasi, Rachel Anderson, Mehmed Taha Dinc, Eva Gaufberg, Kayra Cengiz, Sainikhil Sontha, Janice Weinberg, Patrick Kurpaska, Yashvin Onkarappa Mangala, Matthew Kulke, Umit Tapan

18 Jun 2026

https://doi.org/10.3332/ecancer.2026.2150

Abstract | Full Article | PDF

2149-bringing-leaders-together-to-support-the-development-of-childrens-palliative-care-across-the-asia-pacific-region-an-interdisciplinary-workshop

Conference Report: Bringing leaders together to support the development of children’s palliative care across the Asia Pacific region—an interdisciplinary workshop

Gemma E Aburn, Rima Saad Rassam, Ximena Garcia-Quintero, Marta Salek, Andrea Cuviello, Yadurshini Raveendran, Sri Andini Handayani, Chen Chen Sun, Su Yadana, Sally Blair, Megan Doherty, Min Sun Kim, Zhou Xuan, Marianne B Phillips, Lee Ai Chong, Gayatri Palat, Donna Drew, Justin N Baker, Poh Heng Chong, Julia Downing, Michael J McNei

17 Jun 2026

https://doi.org/10.3332/ecancer.2026.2149

Abstract | Full Article | PDF

2147-benchmarking-of-radiobiological-ntcp-models-in-head-and-neck-radiotherapy-using-independent-computational-pipelines-an-institutional-validation-study-with-machine-learning-augmentation

Research: Benchmarking of radiobiological NTCP models in head and neck radiotherapy using independent computational pipelines: an institutional validation study with machine learning augmentation

Kalyan Mondal, Abhijit Mandal, Anuj Vijay1c, Ganeshkumar Patel

16 Jun 2026

https://doi.org/10.3332/ecancer.2026.2147

Abstract | Full Article | PDF

2144-use-of-low-dose-immune-checkpoint-inhibitors-in-low-and-middle-income-countries-a-national-survey-of-oncologists-and-hematologists-in-mexico

Research: Use of low-dose immune checkpoint inhibitors in low- and middle-income countries: a national survey of oncologists and hematologists in Mexico

Andres Meraz-Brenez, Enrique Soto-Perez-De-Celis, Roberta Demichelis-Gomez, Leonardo Verduzco-Rodriguez, Arjun Gupta, Meera Ragavan, Fumiko Chino, Haydee Cristina Verduzco-Aguirre

10 Jun 2026

https://doi.org/10.3332/ecancer.2026.2144

Abstract | Full Article | PDF